Amy Dawson
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Ovarian cancer diagnosis and treatment 9
- Oncology 5
- Cytokine Signaling Pathways and Interactions 2
- Cancer Cells and Metastasis 2
- Co-authors
- Marta Llauradó Fernández (8 shared papers)Mark Carey (8 shared papers)Michael S. Anglesio (2 shared papers)Paul J. Yong (1 shared paper)John Greenman (2 shared papers)John Macfie (1 shared paper)M. Jacobsen (1 shared paper)J. Davies (1 shared paper)
- Journals
- Biomicrofluidics (2 papers)Molecular Cancer Therapeutics (1 paper)Journal of Gynecologic Oncology (1 paper)Cancer Cell International (1 paper)Gynecologic Oncology (1 paper)
- Partner nations
- CanadaIrelandUnited Kingdom
In The Last Decade
Amy Dawson
12 papers receiving 273 citations
Peers
Comparison fields: 5 of 52
- Reproductive Medicine 169
- Obstetrics and Gynecology 79
- Cancer Research 39
- Oncology 67
- Pathology and Forensic Medicine 43
Countries citing papers authored by Amy Dawson
This map shows the geographic impact of Amy Dawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Dawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Dawson more than expected).
Fields of papers citing papers by Amy Dawson
This network shows the impact of papers produced by Amy Dawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Dawson. The network helps show where Amy Dawson may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Dawson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 78 | |
| 2 | 2016 | 49 | |
| 3 | Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines. | 2016 | 32 |
| 4 | 2020 | 27 | |
| 5 | 2021 | 26 | |
| 6 | 2019 | 26 | |
| 7 | 2022 | 13 | |
| 8 | 2016 | 13 | |
| 9 | 2022 | 9 | |
| 10 | Microfluidics : the fur-free way towards personalised medicine in cancer therapy | 2016 | 4 |
| 11 | 2025 | 3 | |
| 12 | 2017 | 1 |
About Amy Dawson
Amy Dawson is a scholar working on Reproductive Medicine, Oncology, Pathology and Forensic Medicine, Cancer Research and Biomedical Engineering, having authored 12 papers that have together received 281 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (9 papers), Cancer Mechanisms and Therapy (4 papers), Cancer Genomics and Diagnostics (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer Cells and Metastasis (2 papers), Microfluidic and Bio-sensing Technologies (2 papers), 3D Printing in Biomedical Research (2 papers) and Kruppel-like factors research (1 paper). The work is most often cited by research in Reproductive Medicine (169 citations), Obstetrics and Gynecology (79 citations), Cancer Research (39 citations), Oncology (67 citations) and Pathology and Forensic Medicine (43 citations). Amy Dawson has collaborated with scholars based in Canada, Ireland and United Kingdom. Frequent co-authors include Marta Llauradó Fernández, Mark Carey, Michael S. Anglesio, Paul J. Yong, John Greenman, John Macfie, M. Jacobsen, J. Davies, Charlotte E. Dyer and Gabriel E. DiMattia. Their work appears in journals such as Biomicrofluidics, Molecular Cancer Therapeutics, Journal of Gynecologic Oncology, Cancer Cell International and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.